AGP Wire

AGP

BEMOR, the Quanzhou-based footwear manufacturer, is positioning its ODM light-weight casual white student shoes for school uniform suppliers, retail buyers and distributors ahead of back-to-school demand.

AGP

MWE has released a handover guide for retail teams that must transfer responsibility for in-store displays to a new manager.

AGP

Dad Rocks has unveiled its concept poster in Beijing, introducing a family film built around a middle-aged father who returns to music and reconnects with his son. The production is positioning the movie as a more market-driven alternative to…

AGP

BEMOR is positioning itself as a China-based supplier for large-size women’s sandals as overseas retailers and e-commerce sellers struggle to source extended sizing.

AGP

HENAN MEFU INDUSTRIAL LIMITED says it is strengthening its position in roll laminators, flatbed laminators, applicators and cutters through independent testing, patents and product documentation.

AGP

The Atgam market is expected to expand through 2035 as organ transplant volumes rise and older patients need more immune-suppressing care.

AGP

The Business Research Company says the global Attenuvax market is set for steady growth through 2026-2035 as measles outbreaks, childhood immunization efforts and public health spending support demand.

AGP

The Business Research Company says the global market for Asparlas (calaspargase pegol) is rising on demand for targeted leukemia therapies and longer-acting formulations.

AGP

The global Avastin (bevacizumab) market is projected to keep growing as cancer cases rise, healthcare spending increases and biosimilars expand access.

AGP

The Business Research Company says the global Audenz vaccine market is being shaped by rising concern over zoonotic disease, stockpiling for pandemics and broader immunization efforts.

AGP

The Business Research Company says the Autoplex market is set to expand as hemophilia diagnoses rise, healthcare spending increases and more patients need inhibitor-management therapies.

AGP

The Business Research Company says the adult spinal deformity market is set to grow from $2.73 billion in 2026 to $3.37 billion by 2030, driven by aging populations, obesity, and wider use of minimally invasive spine procedures.

AGP

The global market for adult T-cell leukemia/lymphoma treatment is forecast to grow from $2.16 billion in 2026 to $2.99 billion by 2030, driven by clinical-trial activity, targeted therapies and broader cancer-care capacity.

AGP

The global Avonex market is projected to rise from $1.95 million in 2025 to $2.58 million by 2030, driven by growing multiple sclerosis diagnoses and continued demand for long-term injectable therapies.

AGP

The adult stem cell assay market is forecast to grow from $11.93 billion in 2025 to $24.75 billion by 2030, driven by regenerative medicine, cell-based drug discovery and lab automation.

AGP

The advanced liver cancer market is projected to grow from $2.49 billion in 2026 to $4.27 billion by 2030, driven by rising hepatitis infections, broader use of genomic testing, and expanding diagnostic capacity.

AGP

The Business Research Company released a 2026 global Atryn market report on Oct. 30, 2026, projecting demand growth through 2035 as chronic disease rates, personalized medicine, and surgical risk management drive use of recombinant antithrombin…

AGP

The Business Research Company says the Brineura market is set for long-term growth through 2035, driven by rising genetic disorder diagnoses, orphan-drug support and stronger rare-disease care networks.

AGP

The Business Research Company projects the global advanced melanoma market will grow from $4.5 billion in 2026 to $6.37 billion by 2030. The report points to rising melanoma cases, stronger treatment adoption and faster growth in Asia-Pacific,…

AGP

The advanced recurrent ovarian cancer market is projected to grow from $2.71 billion in 2025 to $2.93 billion in 2026, according to The Business Research Company.